Safety and Clinical Performance of a Sirolimus-eluting Absorbable Metal Scaffold

A trial with no phase registered on ClinicalTrials.gov. The registry status is suspended. It plans to enroll 100 participants.

Also called NCT02916485

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
  • Biotronik AG Registry lists this organization as the lead sponsor
Registry
  • NCT NCT02916485
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
India (from the registry)
Registry status
  • Suspended (from the registry)

Technical summary

Registry record NCT02916485. Allocation not applicable; no masking; primary purpose treatment. Start 2017-06 (anticipated); primary completion 2018-02 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety and Clinical Performance of a Sirolimus-eluting Absorbable Metal Scaffold
Acronym
BIOSOLVE-India
Intervention (Device)
Bioresorbable scaffold
Lead sponsor
Biotronik AG (class: industry)
Collaborator
CBCC-VIBGYOR Research Pvt. Ltd. (class: other)

Record details

Record id
cardio:ct-nct02916485
Content hash
643ab46d5680097e9b50fa5c35bf291beb8f819d4f670c2a2aaa0054a17f2d0c